Analyst consensus rating
ProKidney Analyst Rating: none
Direct answer
ProKidney's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.88.
Forecast evidence checked November 14, 2026.
Get free ProKidney email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.05
- Average price target
- $7.88
- High price target
- $12.00
- Low price target
- $4.50
- Low target gap
- +330.6%
- Target upside
- +653.6%
- High target gap
- +1,048.3%
- Target range width
- 717.7%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for ProKidney?
ProKidney has a verified none consensus. The same dataset has an average price target of $7.88.
How far are ProKidney's low and high targets from the recorded price?
The low target implies +330.6%, while the high target implies +1,048.3%.
How many analysts are included in ProKidney's consensus?
The verified consensus includes 4 analysts.
How is ProKidney's target upside or downside calculated?
The average target of $7.88 is divided by the recorded price of $1.05, then one is subtracted to produce +653.6%. This does not guarantee a future return.
When was ProKidney's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.